TWD 72.7
(-0.41%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 3.22 Billion TWD | 8.79% |
2022 | 3.02 Billion TWD | 9.16% |
2021 | 2.76 Billion TWD | 6.27% |
2020 | 2.6 Billion TWD | -8.77% |
2019 | 2.85 Billion TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 807.78 Million TWD | 3.04% |
2024 Q1 | 772.85 Million TWD | -11.66% |
2023 FY | 3.28 Billion TWD | 8.79% |
2023 Q3 | 942.35 Million TWD | 24.08% |
2023 Q4 | 874.89 Million TWD | -7.16% |
2023 Q1 | 710.35 Million TWD | -12.0% |
2023 Q2 | 759.47 Million TWD | 6.91% |
2022 Q4 | 807.24 Million TWD | 0.0% |
2022 FY | 3.02 Billion TWD | 9.16% |
2021 FY | 2.76 Billion TWD | 6.27% |
2020 FY | 2.6 Billion TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | -1208.101% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | -1025.776% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | -1788.302% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | -52.065% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | -50.132% |
Center Laboratories, Inc. | 618.09 Million TWD | -421.55% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | -1026.575% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | -587.838% |
InnoPharmax Inc. | 17.45 Million TWD | -18366.357% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -1217.758% |
Excelsior Biopharma Inc. | 306.93 Million TWD | -950.296% |
DV Biomed Co., Ltd. | 764.27 Million TWD | -321.794% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | -2728.477% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | -191.73% |
UniPharma Co., Ltd. | 51.01 Million TWD | -6218.943% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -712.143% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | -591.892% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | -827.414% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -544439.189% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | -4051.488% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | -706.122% |